NCT04515342

Brief Summary

This study is a cross-sectional study that wishes to investigate whether there is an increased incidence of sarcopenia in patients with chronic kidney disease compared to the Danish background population. A possible association between sarcopenia and fall, as well as the incidence of osteoporosis in patients with chronic kidney disease will also be described.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

4.8 years

First QC Date

August 13, 2020

Last Update Submit

April 19, 2024

Conditions

Keywords

FallChronic kidney disease-mineral and bone disorder (CKD-MBD)

Outcome Measures

Primary Outcomes (1)

  • Difference in appendicular lean body mass

    Difference in appendicular lean body mass between patients with chronic kidney disease and a healthy control group examined in a previous study

    Day 0 (day of study procedure)

Secondary Outcomes (8)

  • Difference in the incidence of sarcopenia

    Day 0 (day of study procedure)

  • Difference in appendicular muscle mass

    Day 0 (day of study procedure)

  • Difference in handgrip strength

    Day 0 (day of study procedure)

  • Difference in gait speed

    Day 0 (day of study procedure)

  • Difference in sit-to-stand test

    Day 0 (day of study procedure)

  • +3 more secondary outcomes

Study Arms (1)

Participants

This is a cross-sectional study involving approximately 150 patients. They undergo a physical examination, fill out a questionnaire, have blood samples drawn, undergo a Dual Energy X-ray Absorptiometry (DXA) scan and different physical procedures to assess muscle strength and muscle function.

Diagnostic Test: DXAOther: Muscle strength and function assessmentOther: Blood samples

Interventions

DXADIAGNOSTIC_TEST

Each participant will undergo one DXA scan

Participants

Each patient will have their muscle strength and function assessed with the measurements of handgrip strength, 10 m gait speed and a 30 s sit-to-stand test. They will also fill out a questionnaire assessing Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F questionnaire).

Participants

Each patient will undergo a physical examination and also deliver blood samples.

Participants

Eligibility Criteria

Age20 Years - 120 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients will be recruited from the Department of Nephrology at both Herlev Hospital and Odense University Hospital during their regular visits to these outpatient clinics. All subjects connected to the participating centers are screened to see if they are eligible for the study. Participants with a minimum age of 20 with eGFR ≤30 ml/min are asked if they wish to be examined further to see if they meet all the inclusion criteria and none of the exclusion criteria. Only participants meeting all the inclusion criteria and none of the exclusion criteria will be considered eligible for the trial.

You may qualify if:

  • Age ≥20 years
  • Chronic kidney disease stage 4-5 not on dialysis (nonD) (corresponding to an estimated glomerular filtration rate (eGFR) ≤30 ml/min based on Kidney Disease Improving Global Outcomes (KDIGO) definition and not on dialysis)

You may not qualify if:

  • Kidney transplanted
  • Immobilized/hospitalized for more than 1 week within the last 6 weeks
  • Active treatment with growth hormone or sex hormone
  • Known muscle disease
  • The lack of ability to speak or understand Danish
  • The lack of ability to give an informed consent
  • The lack of ability to participate in a clinical study based on the assessment by the local investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Herlev and Gentofte Hospital, Herlev Hospital

Herlev, 2730, Denmark

RECRUITING

Odense University Hospital

Odense, 5000, Denmark

NOT YET RECRUITING

Related Publications (1)

  • Suetta C, Haddock B, Alcazar J, Noerst T, Hansen OM, Ludvig H, Kamper RS, Schnohr P, Prescott E, Andersen LL, Frandsen U, Aagaard P, Bulow J, Hovind P, Simonsen L. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20-93 years. J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1316-1329. doi: 10.1002/jcsm.12477. Epub 2019 Aug 16.

    PMID: 31419087BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples (serum, plasma)

MeSH Terms

Conditions

SarcopeniaRenal Insufficiency, ChronicOsteoporosisBone DiseasesChronic Kidney Disease-Mineral and Bone Disorder

Interventions

Muscle StrengthBlood Specimen Collection

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesBone Diseases, MetabolicMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesRicketsCalcium Metabolism DisordersVitamin D DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersHyperparathyroidism, SecondaryHyperparathyroidismParathyroid DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Physical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaSpecimen HandlingClinical Laboratory TechniquesPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Ditte Hansen, MD, PhD

    Department of Nephrology, Herlev and Gentofte Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, MD, PhD

Study Record Dates

First Submitted

August 13, 2020

First Posted

August 17, 2020

Study Start

March 10, 2021

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

For now no Individual Participant Data (IPD) are planned to be shared with other researchers.

Locations